Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Esters to Carboxylic Acids: Saponification01:25

Esters to Carboxylic Acids: Saponification

Esters can be hydrolyzed to carboxylic acids under acidic or basic conditions. Base-promoted hydrolysis of esters is a nucleophilic acyl substitution reaction in which esters react with an aqueous base, followed by an acid to give carboxylic acids. This reaction is also known as saponification because it forms the basis for making soaps from fats.
The reaction requires a base in stoichiometric amounts, which participates in the reaction and is not regenerated later. So, the base acts as a...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
β-Dicarbonyl Compounds via Crossed Claisen Condensations01:18

β-Dicarbonyl Compounds via Crossed Claisen Condensations

Crossed Claisen condensations are base-promoted reactions between two different ester molecules producing β-dicarbonyl compounds. The reaction involving esters, with both containing α hydrogen, results in a mixture of four different products that are difficult to isolate. This reduces the synthetic utility of the reaction.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy.

Menopause (New York, N.Y.)·2025
Same author

Retraction notice to "A pilot efficacy study with a single-rod contraceptive implant (Implanon®1) in 200 Indonesian women treated for ≤ 4 years" [Contraception 59/3 (1999) 167-174].

Contraception·2025
Same author

The rediscovery of estetrol and its implications for estrogen treatment.

Menopause (New York, N.Y.)·2025
Same author

Premature ovarian insufficiency and the risk of breast cancer.

Human reproduction open·2025
Same author

Premature ovarian insufficiency and the risk of breast cancer.

Climacteric : the journal of the International Menopause Society·2025

Related Experiment Video

Updated: Jun 26, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Clinical applications for estetrol.

Monique Visser1, Herjan J T Coelingh Bennink

  • 1Pantarhei Bioscience, PO Box 464, 3700 AL Zeist, The Netherlands. mv@pantarheibio.com

The Journal of Steroid Biochemistry and Molecular Biology
|January 27, 2009
PubMed
Summary

Estetrol (E4), a human fetal estrogen, shows promise as an effective oral therapy. Its unique properties allow for estrogen agonism with breast antagonism, suggesting applications in hormone replacement and contraception.

More Related Videos

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
14:13

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

Published on: January 1, 2018

Related Experiment Videos

Last Updated: Jun 26, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
14:13

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

Published on: January 1, 2018

Area of Science:

  • Endocrinology
  • Pharmacology
  • Reproductive Medicine

Background:

  • Estetrol (E4), a human fetal estrogen, was previously considered a weak estrogen due to low receptor affinity.
  • Recent studies reveal favorable pharmacokinetics, including slow elimination and long half-life for E4.
  • E4 exhibits unique properties: oral bioavailability, estrogen agonism, and estrogen antagonism in the breast when co-administered with estradiol.

Purpose of the Study:

  • To present the potential clinical applications of estetrol (E4).
  • To evaluate E4's suitability for various therapeutic uses based on recent data.

Main Methods:

  • Review of preclinical and clinical study data.
  • Analysis of pharmacokinetic properties, pharmacological profile, safety, and efficacy.

Main Results:

  • E4 demonstrates effective oral bioavailability.
  • E4 acts as an estrogen agonist with specific antagonistic effects on the breast.
  • Human studies indicate favorable safety and efficacy profiles for E4.

Conclusions:

  • Estetrol (E4) shows potential for hormone replacement therapy (vaginal atrophy, vasomotor symptoms).
  • E4 may be suitable for contraception, osteoporosis management, and breast cancer treatment.
  • The favorable pharmacokinetic and safety profile supports E4's clinical utility.